The Division of Infectious Disease at Brigham & Women's Hospital (BWH) is a part of the Brigham Medical Specialties (BMS) and is affiliated with Harvard Medical School. We provide the highest quality patient care and exceptional consultative service to the Brigham and Women’s Hospital community, while also advancing the hospital’s goals of creative biomedical research and teaching. The division consists of a diversified group of clinicians, clinical and research investigators, epidemiologists, and social scientists.
The missions of the Division of Infectious Diseases are to provide high quality inpatient and outpatient care and consultative services to the BWH patient and healthcare communities; to teach clinical infectious disease to our exceptionally able medical and medical postgraduate trainees; to create educational materials that widely disseminate knowledge of prevention, diagnosis, and treatment of infectious diseases; and to develop creative basic biomedical laboratory, patient-oriented, or population-oriented research that has the potential to change global approaches to infectious and infection-related diseases.
The division has outstanding ambulatory and inpatient consultative teams, prepared to deal with infectious disease problems that may arise in people from any setting. The clinical service operates an outpatient office practice and an inpatient consultation service. We also operate a global travel health clinic that service provides pre-travel planning, immunization, and advice for travelers in the avoidance of diseases.
Exceptional student, resident, and fellow teaching and training enhance HMS education in related areas. The Division's research efforts are based at several locations, including the Channing Laboratory, the Harvard School of Public Health, the Department of Social Medicine at Harvard Medical School, and affiliated laboratory space at Landsdowne Street in Cambridge. The Clinical Microbiology Laboratory offers a full range of procedures for isolation and identification of bacterial, mycobacterial, fungal, parasitic and viral infections; antibiotic susceptibility testing; and serology tests for infectious agents. Faculty and trainee research focuses on HIV/AIDS therapeutics and vaccine development; basic research in HIV and viral oncology; novel therapeutic approaches to infection and cancer in immune-compromised people; hospital and community epidemiology; molecular pathogenesis, prevention, and immune therapeutics for virus-induced malignant diseases, bacterial, mycobacterial, and fungal infections; clinical and epidemiologic research in the HMS system; worldwide surveillance of antibiotic resistance; and a partnership with colleagues in the Division of Global Health Equity in new approaches to the sustainable prevention and treatment of infectious diseases in Massachusetts and in resource-deficient settings.
Please browse our website to learn more about the care available within our division. We thank you for choosing us.
Send Feedback to: Jillian Arenz
This page was last modified on 2/23/2013